Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China

ETHNOPHARMACOLOGICAL RELEVANCE: The coronavirus disease 2019 (COVID-19) has formed a global pandemic since late 2019. Benefitting from the application experience of Chinese Medicine (CM) for influenza and SARS, CM has been used to save patients at the early stage of COVID-19 outbreak in China. AIM O...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Lu, Cheng, Li, Hao, Qi, Wensheng, Ruan, Lianguo, Bian, Yongjun, Shi, Huaxin, Song, Hui, Tu, Shengjin, Zhang, Yan, Bai, Tao, Cao, Rong, Hong, Ke, Li, Huadong, Liu, Li, Lu, Sixia, Rong, Nianhe, Liu, Yue, Fang, Jiliang, Shi, Jiaheng, Yang, Wei, Zhao, Bin, Yang, Yang, Zhao, Yufeng, Li, Shaoyuan, Fan, Tiebing, Rong, Peijing, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847283/
https://www.ncbi.nlm.nih.gov/pubmed/33529638
http://dx.doi.org/10.1016/j.jep.2021.113888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847283/
https://www.ncbi.nlm.nih.gov/pubmed/33529638
http://dx.doi.org/10.1016/j.jep.2021.113888

Ejemplares similares